Skip to Content
US Videos

This Mid-Blend Fund Seeks Diamonds in the Rough

Silver-rated First Eagle Fund of America has driven strong returns by rooting out companies with unrecognized potential.

Mentioned:

Greg Carlson: This week's Morningstar Medalist is First Eagle Fund of America (FEAFX). This fund resides in Morningstar's mid-blend category. However, the overall portfolio tends to own a mix of mid- and large-cap stocks. The managers typically buy mid-cap stocks; however, a lot of their winners will blossom into large-cap territory, and they continue to hold on for the long haul as long as things work well. So, you might say that they start out as value investors but end up holding some stocks that are classified as growth stocks, such as Valeant Pharmaceuticals (VRX), for example, which is a biotech company.

They invest in companies that are undergoing corporate change. These typically are companies that have had management changes or some type of restructuring. They also look for companies that have some sort of hidden asset that hasn't been recognized by the market.

Greg Carlson does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.